JAMP Pharma Group Chooses SciMax Global as Their Medical Information Provider
SciMax Global, is excited to announce that JAMP Pharma Corporation has selected The SciMax MI medical information solution. JAMP was introduced to SciMax through an ongoing relationship with Techsol Life Sciences, thus leading to JAMP Pharma Group choosing SciMax Global, a leading scientific communications and medical affairs consulting and technology provider as their medical information partner. SciMax Global will launch SCIMAX MI with an integration to JAMP’s Pharma Group Argus Safety System over the course of the next 18-24 weeks.
The successful implementation of SCIMAX MI, as with any business-critical system, depends on collaboration, preparation, planning, communication, and clearly set and agreed upon expectations regarding deliverables, timelines, and success criteria. “It is exciting to have the opportunity to collaborate and begin project planning with the JAMP team and share their excitement when walking through the many functionalities of SCIMAX MI”, states Dayana Popa, the project manager for this engagement. As part of our standard process the teams will hold configuration workshop sessions to document and apply specific business process requirements to our highly configurable SCIMAX MI system. Once signoffs for all configurations are finalized and locked down, the validation testing phase of this project will include SciMax-created installation and operational qualifications. Auvi Ruelos, COO states “The beginning of the Validation testing phase is the culmination of all the work that has been completed by both the JAMP and the SciMax teams. The work completed to this point includes creating and approving the Configuration Specification Document, Validation Plan, testing protocols, test scripts, and traceability matrix among other validation deliverables.”
Our experience working with Medical Information and Medical Affairs departments in pharmaceutical and biotech industries spans the globe and enables us to go far beyond just a technology or department-oriented solution. “JAMP Pharma has shown a strong growth in the past years and to support our evolution, we are pleased to collaborate with an innovative company such as SciMax.”, mentions Danny Germain, Vice-President Regulatory Affairs at JAMP Pharma. “This is an important milestone for us and will definitely help to optimize our internal resources.”
Our strategic services build a bridge from business to technology to accomplish our clients’ goals in new, comprehensive ways. The implementation of the SCIMAX MI solution is completed with the JAMP specific system configurations, products, and medical information content to support regular business processes. In addition, JAMP will leverage our bi-directional Argus Integration to efficiently process safety cases.
The SciMax team looks forward to a long-lasting relationship with the JAMP teams!
About JAMP Pharma Group
JAMP Pharma Group is Canadian based with its head office located in the Greater Montreal area. Having experienced exceptional growth over the past 10 years, JAMP Pharma Group is present in all segments of the pharmaceutical market with a portfolio of more than 325 molecules and is one of the leaders in the industry in terms of annual prescription volume . With more than 130 new products authorized for sale by Health Canada in the last 3 years, the JAMP Pharma Group is the Canadian leader in product launches , enhancing the new treatment options available in Canada, including many specialty drugs. In addition to its generic division, the JAMP Pharma Group has several divisions such as Orimed, BioJAMP, Wampole, Laboratoire Suisse and Cosmetic Import, also offering prescription and branded products, biosimilar products, 180 over-the-counter products with a diverse range of vitamins, supplements, and natural products. The JAMP CareTM patient support program is designed to assist patients, as well as healthcare professionals, in taking specialty medications and biosimilars offered by the JAMP Pharma Group. Website: JAMP Pharma Group (link)
 Source: Pharmaceutical manufacturers with the highest volume of prescriptions in Canada between January 2018 and September 2023. Based in part on data obtained under license from IQVIA Solutions Canada, regarding the following service: CDH, MAT September 2018 to September 2023. All rights reserved. This statement is not necessarily that of IQVIA Solutions Canada Inc. or any of its affiliates or subsidiaries.
 Source: Pharmaceutical manufacturers with the highest volume of reported product launches in Canada between 2016 and 2022 Based in part on data obtained under license from IQVIA Solutions Canada, regarding the following service: CDH, MAT 2016/01 to 2022/12. All rights reserved. This statement is not necessarily that of IQVIA Solutions Canada Inc. or any of its affiliates or subsidiaries.
About SciMax Global
SciMax Global is a leading provider of cutting-edge technology solutions for the pharmaceutical industry, specializing in Scientific Communications and Medical Affairs. By utilizing a unified cloud technology platform and value-driven consulting services, SciMax has demonstrated its ability to assist Pharma and Life Science companies in managing various medical affairs programs. SCIMAX MI (formerly Techsol MIQ), SCIMAX CP, SCIMAX PUBS, SCIMAX IIT, and SCIMAX GRANTS leverage automation, evidence, and insights generation to enhance patient outcomes and care excellence.